3-(3-chloropropoxy)benzamide | 911134-47-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(3-chloropropoxy)benzamide
• CAS: 911134-47-9
• 化学式: C₁₀H₁₂ClNO₂
• 分子量: 213.664
• InChiKey: GCESBLXVZVTBOR-UHFFFAOYSA-N

物化性质

• 沸点：
  369.5±22.0 °C(Predicted)
• 密度：
  1.210±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  52.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  间羟基苯甲酸 在 ammonium hydroxide 、 氯化亚砜 、 potassium carbonate 、 sodium iodide 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 4.5h， 生成 3-(3-chloropropoxy)benzamide
  参考文献：
  名称：

  Synthesis and on-target antibacterial activity of novel 3-elongated arylalkoxybenzamide derivatives as inhibitors of the bacterial cell division protein FtsZ

  摘要：

  Novel 3-elongated arylalkoxybenzamide derivatives were designed, synthesized and evaluated for their cell division inhibitory activity and antibacterial activity. Among them, the subseries of 3-alkyloxybenzamide derivatives exhibited greatly improved on-target activity against Bacillus subtilis and Staphylococcus aureus, and remarkably increased antibacterial activity against B. subtilis ATCC9372, penicillin-susceptible S. aureus ATCC25923, methicillin-resistant S. aureus ATCC29213 (MRSA) and penicillin-resistant S. aureus PR compared with 3-methoxybenzamide. In contrast, the subseries of 3-phenoxyaklyloxybenzamide, 3-heteroarylalkyloxybenzamide and 3-heteroarylthioalkyloxybenzamide derivatives only showed a significant improvement in on-target activity and antibacterial activity against B. subtilis ATCC9372. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.05.056

文献信息

• Compounds Comprising an Oxazole or Thiazole Moiety, Processes for Making Them, and Their Uses
  申请人：Celanire Sylvain

  公开号：US20080275046A1

  公开（公告）日：2008-11-06

  The present invention relates to compounds comprising an oxazole or thiazole moiety of formula (I), processes for preparing them, pharmaceutical compositions comprising said compounds and their uses as H 3 -receptor ligands, Formula (I), wherein, A 1 is CH, C(alkyl), C-halogen or N; R 1 is hydrogen, halogen, C 1-6 alkyl or alkoxy; R 2 is, Formula (II′), A 3 is O or S; R 3 is hydrogen, halogen, C 1-6 alkyl or alkoxy; R 4 is hydrogen, halogen, C 1-6 alkyl, alkoxy or —O-L; R 5 is hydrogen or —O-L, wherein L is an aminoalkyl group and at least one of R 4 and R 5 should be —O-L.

  本发明涉及一种包含氧唑或噻唑基团的化合物，其化学式为(I)，以及制备它们的方法、包含该化合物的药物组合物以及其作为H3受体配体的用途，式(I)中，A1为CH、C(烷基)、C-卤或N；R1为氢、卤素、C1-6烷基或烷氧基；R2为式(II')、A3为O或S；R3为氢、卤素、C1-6烷基或烷氧基；R4为氢、卤素、C1-6烷基、烷氧基或-O-L；R5为氢或-O-L，其中L为氨基烷基团，且R4和R5中至少有一个应为-O-L。
• COMPOUNDS COMPRISING AN OXAZOLE OR THIAZOLE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES
  申请人：UCB Pharma, S.A.

  公开号：EP1866293A1

  公开（公告）日：2007-12-19
• US7790720B2
  申请人：——

  公开号：US7790720B2

  公开（公告）日：2010-09-07
• [EN] COMPOUNDS COMPRISING AN OXAZOLE OR THIAZOLE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES<br/>[FR] COMPOSES COMPRENANT UN GROUPE FONCTIONNEL D'OXAZOLE OU DE THIAZOLE, PROCESSUS DE FABRICATION ET LEUR UTILISATION
  申请人：UCB SA

  公开号：WO2006103045A1

  公开（公告）日：2006-10-05

  [EN] The present invention relates to compounds comprising an oxazole or thiazole moiety of formula (I), processes for preparing them, pharmaceutical compositions comprising said compounds and their uses as H₃ -receptor ligands, Formula (I), wherein , A¹ is CH, C(alkyl), C-halogen or N; R^l is hydrogen, halogen, C_1-6 alkyl or alkoxy; R² is, Formula (II'), A³ is O or S; R³ is hydrogen, halogen, C_1-6 alkyl or alkoxy; R⁴ is hydrogen, halogen, C_1-6 alkyl, alkoxy or -O-L; R⁵ is hydrogen or -O-L, wherein L is an aminoalkyl group and at least one of R⁴ and R⁵ should be -O-L.
  [FR] La présente invention concerne des composés comprenant un groupe fonctionnel à base d'oxazole ou de thiazole ayant la formule (I), des processus de préparation, des compositions pharmaceutiques comprenant ces composés et leur utilisation en tant que ligands de récepteurs H₃, formule (I), dans laquelle A¹ et CH, C(alkyle), C-halogène ou N; R¹ est hydrogène, halogène, alkyle ou alcoxy C_1-6; R² est, formule (II'), A³ est O ou S; R³ est hydrogène, halogène, alkyle ou alcoxy C_1-6; R⁴ est hydrogène, halogène, alkyle ou alcoxy C_1-6 ou -O-L; R⁵ est hydrogène ou -O-L, dans laquelle L est un groupe aminoalkyle, au moins des R⁴ et R⁵ devant être -O-L.
• Synthesis and on-target antibacterial activity of novel 3-elongated arylalkoxybenzamide derivatives as inhibitors of the bacterial cell division protein FtsZ
  作者：Siti Ma、Chao Cong、Xiaohui Meng、Shasha Cao、Hongkun Yang、Yuanyuan Guo、Xueyi Lu、Shutao Ma

  DOI：10.1016/j.bmcl.2013.05.056

  日期：2013.7

  Novel 3-elongated arylalkoxybenzamide derivatives were designed, synthesized and evaluated for their cell division inhibitory activity and antibacterial activity. Among them, the subseries of 3-alkyloxybenzamide derivatives exhibited greatly improved on-target activity against Bacillus subtilis and Staphylococcus aureus, and remarkably increased antibacterial activity against B. subtilis ATCC9372, penicillin-susceptible S. aureus ATCC25923, methicillin-resistant S. aureus ATCC29213 (MRSA) and penicillin-resistant S. aureus PR compared with 3-methoxybenzamide. In contrast, the subseries of 3-phenoxyaklyloxybenzamide, 3-heteroarylalkyloxybenzamide and 3-heteroarylthioalkyloxybenzamide derivatives only showed a significant improvement in on-target activity and antibacterial activity against B. subtilis ATCC9372. (C) 2013 Elsevier Ltd. All rights reserved.